Profilo
Jason Carlton worked as an Executive Director of Clinical Operations at Ultragenyx Pharmaceutical, Inc. and as the Head of Global Clinical Operations at Genentech, Inc. He also worked as a Vice President of Clinical Operations at Jasper Therapeutics, Inc. for a brief period in 2022.
Mr. Carlton completed his undergraduate degree at LaSalle University.
Precedenti posizioni note di Jason Carlton
Società | Posizione | Fine |
---|---|---|
JASPER THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2022 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
ULTRAGENYX PHARMACEUTICAL INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Jason Carlton
LaSalle University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
JASPER THERAPEUTICS, INC. | Finance |
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
Aziende private | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Jason Carlton